Michael Rice - Oct 30, 2023 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
Former CEO and Director
Signature
/s/ Michael Rice
Stock symbol
BLFS
Transactions as of
Oct 30, 2023
Transactions value $
-$662,865
Form type
4
Date filed
11/1/2023, 05:30 PM
Previous filing
Oct 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Sale -$663K -72.6K -17.3% $9.13 347K Oct 30, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Michael Rice is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported herein was made pursuant to Rule 10b5-1 (c) trading plans adopted by the reporting person effective as of 03-25-2020, 02-08-21, 02-24-2022, and 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.